Progress in the pharmacological management of vasovagal syncope
Patients usually do well and respond to ongoing support and simple dietary advice and physical tips. Some benefit from fludrocortisone, midodrine, or serotonin-specific reuptake inhibitors. Almost all patients eventually stop fainting, and invasive treatments should be used last and for the very few highly afflicted patients who do not improve with safer measures.
Authors
- Robert S. Sheldon (ORCID: https://orcid.org/0000-0003-0742-8379)
- Martina Rafanelli (ORCID: https://orcid.org/0000-0002-8277-9710)
- Vincenzo Giosuè Giambusso
Institutions
- University of Calgary (CA)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- University of Florence (IT)
Publication Details
- Journal
- Expert Review of Clinical Pharmacology
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1080/17512433.2025.2596875
- Citations
- 1
- Primary Topic
- Cardiovascular Syncope and Autonomic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.01